Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Allergan
Allergan
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
Wed, 06/26/19 - 11:51 am
AbbVie
Allergan
M&A
R&D
layoffs
Here's Why Nobody's Happy About This $63 Billion Buyout
Motley Fool
Wed, 06/26/19 - 10:41 am
AbbVie
Allergan
M&A
How Brent Saunders’ Allergan experiment failed
Stat
Wed, 06/26/19 - 10:12 am
Brent Saunders
Allergan
AbbVie
Pharma CEOs
AbbVie’s $63 Billion Mistake
Motley Fool
Tue, 06/25/19 - 07:20 pm
AbbVie
Allergan
M&A
AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
Stat
Tue, 06/25/19 - 09:18 am
AbbVie
Allergan
M&A
Humira
Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors
Endpoints
Fri, 06/21/19 - 11:48 pm
Allergan
FDA
Botox
pediatric
upper limb spasticity
Analyst call with Allergan execs stokes anticipation of a plan to split the company in ‘a month or two’
Endpoints
Thu, 06/20/19 - 10:06 am
Allergan
Allergan says 'sense of urgency' could prompt move within 60 days
Biopharma Dive
Wed, 06/19/19 - 10:19 am
Allergan
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Wed, 06/19/19 - 09:49 am
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Allergan puts Vraylar on blockbuster track with new bipolar depression nod
Fierce Pharma
Tue, 05/28/19 - 12:21 pm
Allergan
FDA
Vraylar
bipolar disorder
Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch
Fierce Pharma
Thu, 05/16/19 - 11:43 pm
Evolus
Allergan
Jeuveau
drug launches
aesthetics
physicians
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
Endpoints
Tue, 05/7/19 - 10:36 am
Allergan
Brent Saunders
Breast implants tied to rare cancer to remain on US market
Yahoo/AP
Sat, 05/4/19 - 04:51 pm
FDA
breast implants
Allergan
Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics
Endpoints
Wed, 05/1/19 - 12:23 pm
Allergan
Pharma CEOs
Brent Saunders
‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp
Endpoints
Fri, 04/26/19 - 10:27 am
Allergan
Brent Saunders
shareholders
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
Xconomy
Sun, 04/21/19 - 12:16 am
FDA
CRISPR
gene therapy
Achaogen
Allergan
Alnylam
Adverum Biotechnologies
Blackstone Life Sciences
Supreme Court sends Allergan packing over Restasis tribal licensing strategy
Fierce Pharma
Mon, 04/15/19 - 11:51 pm
Allergan
Supreme Court
Restasis
Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan
Endpoints
Mon, 04/15/19 - 10:29 am
Allergan
Brent Saunders
activists
Allergan’s failed depression drug shows promise in opioid withdrawal
Fierce Biotech
Sun, 04/7/19 - 05:13 pm
Allergan
rapastinel
Naurex
opioids
opioid withdrawal
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »